Vancouver Researchers Find That Blood Cells Could Help Screen Ambroxol’s Efficacy in GD Type 3

  A recent article in CheckOrphan describes a study that was conducted by Researchers at the Lysosomal and Rare Disorders Research and Treatment Center in Vancouver, B.C. The study examines the…

Continue Reading Vancouver Researchers Find That Blood Cells Could Help Screen Ambroxol’s Efficacy in GD Type 3

Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients

Alexion Pharmaceuticals, Inc., a company that is advancing a rare disease pipeline in complement biology, recently issued a series of press releases announcing positive results of a Phase 3 study…

Continue Reading Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients

Researchers Find the Future of Ofatumumab in Treating Follicular Lymphoma is Questionable

Ofatumumab as a Single Agent  Results of ofatumumab administered as a single agent with an extended induction (initial treatment) brought about a high response rate and it was well tolerated among follicular…

Continue Reading Researchers Find the Future of Ofatumumab in Treating Follicular Lymphoma is Questionable

Merck’s Keytruda in Combination with Pfizer’s Inlyta Significantly Improved Overall Survival and Progression-Free Survival in Therapy for Metastatic or Advanced Renal Cell Carcinoma

  The treatment of metastatic renal cell carcinoma (RCC) has evolved over the last ten years and investigators now look towards combination therapies to improve response rates and durability for…

Continue Reading Merck’s Keytruda in Combination with Pfizer’s Inlyta Significantly Improved Overall Survival and Progression-Free Survival in Therapy for Metastatic or Advanced Renal Cell Carcinoma
Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients
skeeze / Pixabay

Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients

According to a story from EurekAlert!, a recent study revealed that the surgical removal of the thymus gland, known as a thymectomy, was able to provide long-term benefits for patients…

Continue Reading Study Highlights Long Term Benefits of Thymectomy Surgery for Myasthenia Gravis Patients
Recent Study Demonstrates Smartphone App’s Ability to Detect Early Signs of Movement Disorders
TeroVesalainen / Pixabay

Recent Study Demonstrates Smartphone App’s Ability to Detect Early Signs of Movement Disorders

According to a story from Parkinson's News Today, a recent study describes the ability of an innovative smartphone app that uses touch-based input in order to detect the early signs…

Continue Reading Recent Study Demonstrates Smartphone App’s Ability to Detect Early Signs of Movement Disorders